These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4016049)

  • 21. The movement of xenon-133 from the vitreous to the choroid.
    Moseley H; Foulds WS
    Exp Eye Res; 1982 Feb; 34(2):169-79. PubMed ID: 7060645
    [No Abstract]   [Full Text] [Related]  

  • 22. Clearance of intravitreal 3H-fluorouracil.
    Case JL; Peyman GA; Barrada A; Hendricks R; Fiscella R; Hindi M
    Ophthalmic Surg; 1985 Jun; 16(6):378-81. PubMed ID: 4022559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Experimental depolymerization of hyaluronic acid in rabbit vitreous body. IV. Pathomorphological studies].
    Szram S; Stankiewicz A; Kulig A
    Klin Oczna; 1974 Oct; 14(10):1023-6. PubMed ID: 4420216
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacokinetics and safety of intravitreally delivered etanercept.
    Fauser S; Kalbacher H; Alteheld N; Koizumi K; Krohne TU; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2004 Jul; 242(7):582-6. PubMed ID: 15029504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitreous hemorrhage absorption; experimental study on rabbit eyes of the effects of intravitreal hyaluronidase and streptokinase-strptodornase and on the influence of ACTH and cortisone.
    SCHIMEK RA; STEFFENSEN EH
    Am J Ophthalmol; 1955 May; 39(5):677-83. PubMed ID: 14361628
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of structural changes of vitreous body on the metabolism and morphokinesis of eye structures].
    Stankiewicz A; Szram S; Kulig A
    Klin Oczna; 1975 Dec; 45(12):1243-6. PubMed ID: 1214436
    [No Abstract]   [Full Text] [Related]  

  • 27. Experimental retinal detachment.
    Agarwal LP; Dhiri S; Khosla PK; Sirivastva OP
    Bibl Ophthalmol; 1969; 79():106-10. PubMed ID: 4242198
    [No Abstract]   [Full Text] [Related]  

  • 28. Turnover of hyaluronate in the aqueous humour and vitreous body of the rabbit.
    Laurent UB; Fraser JR
    Exp Eye Res; 1983 Apr; 36(4):493-503. PubMed ID: 6852130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular biology of pharmacologic vitreolysis.
    Sebag J
    Trans Am Ophthalmol Soc; 2005; 103():473-94. PubMed ID: 17057814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of microplasmin on the clearance of vitreous haemorrhage from an experimental model in rabbits.
    Gad Elkareem AM; de Smet MD
    Acta Ophthalmol; 2014 Feb; 92(1):47-50. PubMed ID: 23025384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravitreal pharmacokinetics of plain and liposome-entrapped fluconazole in rabbit eyes.
    Gupta SK; Velpandian T; Dhingra N; Jaiswal J
    J Ocul Pharmacol Ther; 2000 Dec; 16(6):511-8. PubMed ID: 11132898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Electron microscopic investigations of vitreous collagen after treating the vitreous with liquefying substances (author's transl)].
    Schmut O; Roll P; Hofmann H
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1975 Aug; 196(2):187-97. PubMed ID: 169709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo).
    Diakonis VF; Tsourdou A; Tzatzarakis MN; Tsika C; Charisis S; Naoumidi I; Plainis S; Tsilimbaris MK
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):627-32. PubMed ID: 23556534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of enzymatic degradation on dynamic mechanical properties of the vitreous and intravitreal nanoparticle mobility.
    Huang D; Chen YS; Xu Q; Hanes J; Rupenthal ID
    Eur J Pharm Sci; 2018 Jun; 118():124-133. PubMed ID: 29574081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of hyaluronidase on the rate of diffusion in the vitreous body in vivo; experiments with radioactive phosphate on rabbit eyes.
    CRISTIANSSON J
    Acta Ophthalmol (Copenh); 1955; 33(5):571-82. PubMed ID: 13301639
    [No Abstract]   [Full Text] [Related]  

  • 36. The safety of intravitreal hyaluronidase. A clinical and histologic study.
    Gottlieb JL; Antoszyk AN; Hatchell DL; Saloupis P
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2345-52. PubMed ID: 2242999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the molecular biology of the vitreous in the aphakic eye.
    Osterlin S
    Acta Ophthalmol (Copenh); 1977 Jun; 55(3):353-61. PubMed ID: 577345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular pharmacokinetics of intravitreally administered brimonidine and dexamethasone in animal models with and without blood-retinal barrier breakdown.
    Shen J; Durairaj C; Lin T; Liu Y; Burke J
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):1056-66. PubMed ID: 24448267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biochemical concepts of regeneration of vitreous body following experimental depolymerization of hyaluronic acid].
    Stankiewicz A; Szram S; Kulig A
    Klin Oczna; 1975 Dec; 45(12):1237-42. PubMed ID: 1214435
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetics of intraocular drug delivery by periocular injections using ocular fluorophotometry.
    Ghate D; Brooks W; McCarey BE; Edelhauser HF
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2230-7. PubMed ID: 17460284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.